RxDoctor Payments DataLook up a doctor →

Sabrina Robinson Antoine

Family · Greenbelt, MDNPI 1417244559

Payments from drug & device makers

$10,961in general payments, 2019–2025

Across 452 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$929
  • AstraZeneca$661
  • Global Blood Therapeutics, Inc.$563
  • Takeda Pharmaceuticals U.S.A., Inc.$538
  • Pfizer$491
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)49$1,188
Novartis41$929
AstraZeneca(2 entities)26$661
Global Blood Therapeutics, Inc.22$563
Takeda Pharmaceuticals U.S.A., Inc.17$538
Pfizer25$491
Incyte Corporation17$461
Pharmacyclics LLC, An Abbvie Company20$425
E.r. Squibb & Sons, L.L.C.9$396
Merck19$376
Bristol Myers Squibb12$331
Lilly USA, LLC12$301
AbbVie10$297
Amgen13$275
Rigel Pharmaceuticals, Inc.10$241
Gilead(2 entities)10$240
Daiichi Sankyo Inc.9$238
Sanofi9$225
AVEO Pharmaceuticals, Inc.5$168
Exelixis Inc.7$158
GSK5$148
Genentech USA, Inc.6$134
Taiho Oncology, Inc.5$133
Mirati Therapeutics, Inc.4$124
Deciphera Pharmaceuticals Inc.5$113
Regeneron Healthcare Solutions, Inc.5$109
Eisai Inc.5$101
Bayer4$100
EUSA Pharma (US) LLC4$93
G1 Therapeutics, Inc.4$89
Alnylam Pharmaceuticals Inc.5$84
Array Biopharma Inc5$78
Morphosys, US Inc.3$71
Seagen Inc.4$71
Coherus Oncology, Inc.2$67
Tersera Therapeutics LLC3$66
ADC Therapeutics America, Inc.3$65
Pharmacosmos Therapeutics Inc.3$64
Puma Biotechnology, Inc.3$58
Astellas Pharma US Inc3$57
Immunogen, Inc.2$54
Kyowa Kirin, Inc.2$44
Spectrum Pharmaceuticals Inc.2$42
Acrotech Biopharma Inc.2$42
Emmaus Medical, Inc.2$41
Ipsen Biopharmaceuticals, Inc2$41
Pacira Pharmaceuticals Incorporated2$39
Sobi, Inc2$39
Heron Therapeutics, Inc.1$32
Stemline Therapeutics Inc.2$31
Shield Therapeutics Inc1$28
Karyopharm Therapeutics Inc.1$26
Beigene USA, Inc.1$25
EMD Serono, Inc.1$25
Pharmaessentia USA Corporation1$24
Dendreon Pharmaceuticals LLC1$24
Janssen Scientific Affairs, LLC1$23
Epizyme, Inc.1$22
Myriad Genetic Laboratories, Inc.1$16
Foundation Medicine, Inc.1$16

How this compares

$10,961 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland →

Medicare billing

Part B allowed, 2024
$105,317
Medicare patients
466
Services billed
2,295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Greenbelt

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →